Despite the recent launch of congenital adrenal hyperplasia (CAH) drug Crenessity, Neurocrine Biosciences' disappointing ...
The new formulation, marketed as Ingrezza Sprinkle, offers an alternative administration option for adults with tardive dyskinesia and chorea associated with Huntington's disease, who have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback